A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?

This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is ass...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology and immunopathology 1987-06, Vol.43 (3), p.362-373
Hauptverfasser: Skurkovich, S., Skurkovich, B., Bellanti, J.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 373
container_issue 3
container_start_page 362
container_title Clinical immunology and immunopathology
container_volume 43
creator Skurkovich, S.
Skurkovich, B.
Bellanti, J.A.
description This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is associated primarily with the production of the family of IFN-α. In certain immunologically mediated diseases, including the autoimmune diseases and AIDS, disturbances in the synthesis of IFN-α occur with a switch to the production of predominantly acid-labile types, which have a negative immunoregulatory effect. Moreover, disturbances of IFN synthesis in the embryo or fetus can lead to deformities. Some viruses and other biological and chemical substances manifest a pathological effect by the IFN they induce. This IFN may help sustain the viruses and other substances which induce this IFN. We think it is unsafe to give patients immunoregulators in incomplete form. Thus, there is a potential danger in giving patients recombinant forms of IFNs and interleukin 2 produced in bacteria. In certain immune disorders, we may be able to treat patients by the binding or removal of hyperproduced IFNs from the body. This may lead to the restoration of immunologic balance and clinical improvement.
doi_str_mv 10.1016/0090-1229(87)90146-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_14907518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0090122987901462</els_id><sourcerecordid>14907518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-449ca3ff6187a1298a1dce2b660191c676cdf9ddded22b578452c9f7377cb32f3</originalsourceid><addsrcrecordid>eNp9kM1qGzEURkVISd0kb5CCFiE0i2kkjTySumgwpn9gyCZZC1m6ihVmJEeaKfjtO1Mbk1VWgvud7-pyELqi5CsltLkjRJGKMqa-SHGrCOVNxU7QjE5jVnN6imZH5CP6VMoLIaThRJyhM8ZrSUQ9Q68LPMTgdyE-4y45aHHyuN8ADl03xJTheWhNn_IO59TCMYw9ZA85RVx2pYfuG16a-Ha8zckNFrALBUyZGngzdCaW-wv0wZu2wOXhPUdPP388Ln9Xq4dff5aLVWU5FX3FubKm9r6hUhjKlDTUWWDrpiFUUduIxjqvnHPgGFvPheRzZpUXtRB2XTNfn6Ob_d7xlNcBSq-7UCy0rYmQhqIpV0TMqRxBvgdtTqVk8HqbQ2fyTlOiJ9N60qgnjVoK_d-0ZmPt82H_sO7AHUsHtWN-fchNsab12UQbyhGTTHKlpt-_7zEYXfwNkHWxAaIFFzLYXrsU3r_jHwygmzs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14907518</pqid></control><display><type>article</type><title>A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Skurkovich, S. ; Skurkovich, B. ; Bellanti, J.A.</creator><creatorcontrib>Skurkovich, S. ; Skurkovich, B. ; Bellanti, J.A.</creatorcontrib><description>This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is associated primarily with the production of the family of IFN-α. In certain immunologically mediated diseases, including the autoimmune diseases and AIDS, disturbances in the synthesis of IFN-α occur with a switch to the production of predominantly acid-labile types, which have a negative immunoregulatory effect. Moreover, disturbances of IFN synthesis in the embryo or fetus can lead to deformities. Some viruses and other biological and chemical substances manifest a pathological effect by the IFN they induce. This IFN may help sustain the viruses and other substances which induce this IFN. We think it is unsafe to give patients immunoregulators in incomplete form. Thus, there is a potential danger in giving patients recombinant forms of IFNs and interleukin 2 produced in bacteria. In certain immune disorders, we may be able to treat patients by the binding or removal of hyperproduced IFNs from the body. This may lead to the restoration of immunologic balance and clinical improvement.</description><identifier>ISSN: 0090-1229</identifier><identifier>EISSN: 1090-2341</identifier><identifier>DOI: 10.1016/0090-1229(87)90146-2</identifier><identifier>PMID: 2438073</identifier><identifier>CODEN: CLIIAT</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Antibody Formation ; Autoimmune Diseases - immunology ; Biological and medical sciences ; Fundamental and applied biological sciences. Psychology ; Genetics ; Humans ; Immunocompetence ; Interferon Type I - adverse effects ; Interferon Type I - biosynthesis ; Interferon Type I - immunology ; Interferons - immunology ; Interleukin-2 - adverse effects ; Microbiology ; Nephritis, Interstitial - chemically induced ; Recombinant Proteins - adverse effects ; T-Lymphocytes - immunology ; Virology</subject><ispartof>Clinical immunology and immunopathology, 1987-06, Vol.43 (3), p.362-373</ispartof><rights>1987</rights><rights>1987 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-449ca3ff6187a1298a1dce2b660191c676cdf9ddded22b578452c9f7377cb32f3</citedby><cites>FETCH-LOGICAL-c417t-449ca3ff6187a1298a1dce2b660191c676cdf9ddded22b578452c9f7377cb32f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8284998$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2438073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Skurkovich, S.</creatorcontrib><creatorcontrib>Skurkovich, B.</creatorcontrib><creatorcontrib>Bellanti, J.A.</creatorcontrib><title>A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?</title><title>Clinical immunology and immunopathology</title><addtitle>Clin Immunol Immunopathol</addtitle><description>This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is associated primarily with the production of the family of IFN-α. In certain immunologically mediated diseases, including the autoimmune diseases and AIDS, disturbances in the synthesis of IFN-α occur with a switch to the production of predominantly acid-labile types, which have a negative immunoregulatory effect. Moreover, disturbances of IFN synthesis in the embryo or fetus can lead to deformities. Some viruses and other biological and chemical substances manifest a pathological effect by the IFN they induce. This IFN may help sustain the viruses and other substances which induce this IFN. We think it is unsafe to give patients immunoregulators in incomplete form. Thus, there is a potential danger in giving patients recombinant forms of IFNs and interleukin 2 produced in bacteria. In certain immune disorders, we may be able to treat patients by the binding or removal of hyperproduced IFNs from the body. This may lead to the restoration of immunologic balance and clinical improvement.</description><subject>Antibody Formation</subject><subject>Autoimmune Diseases - immunology</subject><subject>Biological and medical sciences</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetics</subject><subject>Humans</subject><subject>Immunocompetence</subject><subject>Interferon Type I - adverse effects</subject><subject>Interferon Type I - biosynthesis</subject><subject>Interferon Type I - immunology</subject><subject>Interferons - immunology</subject><subject>Interleukin-2 - adverse effects</subject><subject>Microbiology</subject><subject>Nephritis, Interstitial - chemically induced</subject><subject>Recombinant Proteins - adverse effects</subject><subject>T-Lymphocytes - immunology</subject><subject>Virology</subject><issn>0090-1229</issn><issn>1090-2341</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1qGzEURkVISd0kb5CCFiE0i2kkjTySumgwpn9gyCZZC1m6ihVmJEeaKfjtO1Mbk1VWgvud7-pyELqi5CsltLkjRJGKMqa-SHGrCOVNxU7QjE5jVnN6imZH5CP6VMoLIaThRJyhM8ZrSUQ9Q68LPMTgdyE-4y45aHHyuN8ADl03xJTheWhNn_IO59TCMYw9ZA85RVx2pYfuG16a-Ha8zckNFrALBUyZGngzdCaW-wv0wZu2wOXhPUdPP388Ln9Xq4dff5aLVWU5FX3FubKm9r6hUhjKlDTUWWDrpiFUUduIxjqvnHPgGFvPheRzZpUXtRB2XTNfn6Ob_d7xlNcBSq-7UCy0rYmQhqIpV0TMqRxBvgdtTqVk8HqbQ2fyTlOiJ9N60qgnjVoK_d-0ZmPt82H_sO7AHUsHtWN-fchNsab12UQbyhGTTHKlpt-_7zEYXfwNkHWxAaIFFzLYXrsU3r_jHwygmzs</recordid><startdate>19870601</startdate><enddate>19870601</enddate><creator>Skurkovich, S.</creator><creator>Skurkovich, B.</creator><creator>Bellanti, J.A.</creator><general>Elsevier Inc</general><general>Academic Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>19870601</creationdate><title>A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?</title><author>Skurkovich, S. ; Skurkovich, B. ; Bellanti, J.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-449ca3ff6187a1298a1dce2b660191c676cdf9ddded22b578452c9f7377cb32f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Antibody Formation</topic><topic>Autoimmune Diseases - immunology</topic><topic>Biological and medical sciences</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetics</topic><topic>Humans</topic><topic>Immunocompetence</topic><topic>Interferon Type I - adverse effects</topic><topic>Interferon Type I - biosynthesis</topic><topic>Interferon Type I - immunology</topic><topic>Interferons - immunology</topic><topic>Interleukin-2 - adverse effects</topic><topic>Microbiology</topic><topic>Nephritis, Interstitial - chemically induced</topic><topic>Recombinant Proteins - adverse effects</topic><topic>T-Lymphocytes - immunology</topic><topic>Virology</topic><toplevel>online_resources</toplevel><creatorcontrib>Skurkovich, S.</creatorcontrib><creatorcontrib>Skurkovich, B.</creatorcontrib><creatorcontrib>Bellanti, J.A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Clinical immunology and immunopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skurkovich, S.</au><au>Skurkovich, B.</au><au>Bellanti, J.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?</atitle><jtitle>Clinical immunology and immunopathology</jtitle><addtitle>Clin Immunol Immunopathol</addtitle><date>1987-06-01</date><risdate>1987</risdate><volume>43</volume><issue>3</issue><spage>362</spage><epage>373</epage><pages>362-373</pages><issn>0090-1229</issn><eissn>1090-2341</eissn><coden>CLIIAT</coden><abstract>This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is associated primarily with the production of the family of IFN-α. In certain immunologically mediated diseases, including the autoimmune diseases and AIDS, disturbances in the synthesis of IFN-α occur with a switch to the production of predominantly acid-labile types, which have a negative immunoregulatory effect. Moreover, disturbances of IFN synthesis in the embryo or fetus can lead to deformities. Some viruses and other biological and chemical substances manifest a pathological effect by the IFN they induce. This IFN may help sustain the viruses and other substances which induce this IFN. We think it is unsafe to give patients immunoregulators in incomplete form. Thus, there is a potential danger in giving patients recombinant forms of IFNs and interleukin 2 produced in bacteria. In certain immune disorders, we may be able to treat patients by the binding or removal of hyperproduced IFNs from the body. This may lead to the restoration of immunologic balance and clinical improvement.</abstract><cop>San Diego, CA</cop><cop>New York, NY</cop><cop>Boston</cop><pub>Elsevier Inc</pub><pmid>2438073</pmid><doi>10.1016/0090-1229(87)90146-2</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-1229
ispartof Clinical immunology and immunopathology, 1987-06, Vol.43 (3), p.362-373
issn 0090-1229
1090-2341
language eng
recordid cdi_proquest_miscellaneous_14907518
source MEDLINE; Alma/SFX Local Collection
subjects Antibody Formation
Autoimmune Diseases - immunology
Biological and medical sciences
Fundamental and applied biological sciences. Psychology
Genetics
Humans
Immunocompetence
Interferon Type I - adverse effects
Interferon Type I - biosynthesis
Interferon Type I - immunology
Interferons - immunology
Interleukin-2 - adverse effects
Microbiology
Nephritis, Interstitial - chemically induced
Recombinant Proteins - adverse effects
T-Lymphocytes - immunology
Virology
title A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T21%3A25%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20unifying%20model%20of%20the%20immunoregulatory%20role%20of%20the%20interferon%20system:%20Can%20interferon%20produce%20disease%20in%20humans?&rft.jtitle=Clinical%20immunology%20and%20immunopathology&rft.au=Skurkovich,%20S.&rft.date=1987-06-01&rft.volume=43&rft.issue=3&rft.spage=362&rft.epage=373&rft.pages=362-373&rft.issn=0090-1229&rft.eissn=1090-2341&rft.coden=CLIIAT&rft_id=info:doi/10.1016/0090-1229(87)90146-2&rft_dat=%3Cproquest_cross%3E14907518%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14907518&rft_id=info:pmid/2438073&rft_els_id=0090122987901462&rfr_iscdi=true